Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


Canaccord Genuity Reaffirms Buy Rating On Edward Lifesciences And Raises Price Target From $103 To $124


Benzinga | Jul 30, 2021 01:55PM EDT

Canaccord Genuity Reaffirms Buy Rating On Edward Lifesciences And Raises Price Target From $103 To $124






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC